. The crisis generated for DuPont a different panorama than other companies and industries, because despite the recession the company's scientists were dedicated to being more creative in the search for productivity and efficiency in innovations, resulting in the production of more than 500 new products in the first quarter of 2009.Uma Chowdhry, Vice President and Chief Science and Technology Officer of DuPont Worldwide, said, "The company's strategy is focused on partnerships with customers and research institutions for the development of new products around the world. We leverage our strengths through innovations that allow us to grow together with our customers in emerging economies."
Due to its high standard of development, the company was listed as the most innovative in the world by the United States Patent Board (The Patent Board), a body that analyzes innovations and value of the patent business, and the scientific journal Nature Biotechnology highlighted DuPont's biotechnology product offering as number one in the agricultural and industrial biotechnology sector.
